One-year access to more than 500 world journals available in the system
-
http://medilib.ir
- Duration of Time : 365 Day
Price : 300$- Special Price : 100$
Journals package 3months
-
http://medilib.ir
- Duration of Time : 93 Day
Price : 100$- Special Price : 50$
Major Bleeding and Mortality After Revascularization of Left Main Disease
Hospitalization of Symptomatic Patients With Heart Failure and Moderate to Severe Functional Mitral Regurgitation Treated With MitraClip: Insights From RESHAPE-HF2
Percutaneous Transcatheter Edge-to-Edge Repair for Functional Mitral Regurgitation in Heart Failure: A Meta-Analysis of 3 Randomized Controlled Trials
A Volume-Based Framework Reconciling COAPT, MITRA-FR, and RESHAPE-HF2
Aspirin Monotherapy vs No Antiplatelet Therapy in Stable Patients With Coronary Stents Undergoing Low-to-Intermediate Risk Noncardiac Surgery
Management of Antiplatelet Therapy After Coronary Stenting in Patients Requiring Noncardiac Surgery
Efficacy and Safety of a Novel Low-Dose Triple Single-Pill Combination Compared With Placebo for Initial Treatment of Hypertension
Treating Hypertension With a Single (Combination) Pill: Changing the Paradigm
High Lipoprotein(a) as a Cause of Kidney Disease: A Population-Based Mendelian Randomization Study
Optimizing AHA/ACC Guidelines for the Digital Age: Guidelines in Evolution
The Reducer Is a Novel, Safe, and Effective Therapy to Optimize the Management of Patients With Stable Angina
Optimizing Management of Stable Angina: Lifestyle Intervention as the Third Pillar
REPLY: Exercise-Based Cardiac Rehabilitation and Coronary Sinus Reducer in the Management of Stable Angina
